Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
boston blog main
4
×
boston top stories
life sciences
national blog main
new york blog main
biotech
curevac
deals
national top stories
new york top stories
san francisco blog main
san francisco top stories
aegle therapeutics
aligos therapeutics
alzheimer's disease
amag pharmaceuticals
aquestive therapeutics
arch venture partners
arimoclomol
astrazeneca
autoimmune diseases
aztherapies
bayer
bial
biomolecular condensates
boston
boulder/denver blog main
boulder/denver top stories
c4 therapeutics
cancer immunotherapy
carmot therapeutics
cell therapy
covid-19. albert bourla
covis group
cstone pharmaceuticals
detroit blog main
detroit top stories
dewpoint therapeutics
diazepam
duchenne muscular dystrophy
What
promise
4
×
bio
cancer
vaccine
amid
bombast
caught
coronavirus
debate
develop
discussion
efforts
meso’s
miss
pandemic
pfizer’s
presidential
response
roundup
tuesday’s
viewers
benefiting
bets
boston
comes
coming
companies
cut
date
deal
diagnostics
effective
enticed
evidence
glimcher
groundbreaking
hasn’t
headline
keynote
latest
Language
unset
Current search:
promise
×
photo
×
" boston blog main "
×
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
4 years ago
Laurie Glimcher To Headline Xconomy Keynote Series in Boston in September
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines